Thrivent Financial for Lutherans’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Thrivent Financial for Lutherans’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,951	Closed	-$605K	–	2457
2023 Q2	$605K	Buy	3,951 +2,237	+131%	+$349K	﹤0.01%	2105
2023 Q1	$266K	Buy	+1,714	New	+$269K	﹤0.01%	2316
2020 Q4	–	Hold	0	–	–	–	2406
2020 Q3	–	Hold	0	–	–	–	2275
2020 Q2	–	Hold	0	–	–	–	1589
2020 Q1	–	Hold	0	–	–	–	1388
2019 Q4	–	Hold	0	–	–	–	1602

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Thrivent Financial for Lutherans's FBT Position: Q3 2023 in Review

Thrivent Financial for Lutherans sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2023, closing a stake of 3,951 shares — an estimated $605K sold.

Thrivent Financial for Lutherans first reported a position in FBT in Q1 2023 and held it in 2 quarters. The position peaked at $605K in Q2 2023. 242 funds tracked by Wall St. Rank hold FBT as of Q3 2023.

Thrivent Financial for Lutherans reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2023 after selling out during the quarter.
Thrivent Financial for Lutherans sold 3,951 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2023, an estimated $605K.
Thrivent Financial for Lutherans first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and held it in 2 quarters.
Thrivent Financial for Lutherans's First Trust NYSE Arca Biotechnology Index Fund position peaked at $605K in Q2 2023.
242 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2023.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2023, filed 14 Nov 2023.